Private Capital (PE & VC) 
Insight(1/5)
Taking hits in Asia
Private equity firms rushed to Asia in the last few years to cash in on the region's booming economy, only to find a tougher than expected deal climate. The economic slowdown and recent market volatility has made the going even worse. Full Article
Merck eyes deals, growth through 2013
Merck's CEO sees profit growth from 2010 to 2013 despite looming generic competition for two of its biggest drugs, and has the appetite to buy a big biotechnology company if the right deal comes along. Full Article
Glitzy Greenwich losing its sparkle
As many hedge funds suffer big losses and anxious investors yank out their money, the town synonymous with the riches of their recent glory is now hurting. Full Article
Japan concerned over BHP/Rio deal
Japan's antitrust watchdog is expected to raise objections soon to BHP Billiton's $78 billion offer for Rio Tinto, hoping to sway European regulators vetting the global mining sector's biggest takeover. Full Article
Cardinal Health confident of spinoff
Drug wholesaler Cardinal Health remains confident it will be able to spin off its medical-device business next year despite the bleak credit environment, the company's CFO says. Full Article
peHUB
- Venture Capital
- Buyouts
- PE M&A
- PE Exits
- Firms & Funds
Global Deals Data
| Company Name | # of Inv. Firms | Value ($M) |
|---|---|---|
| Precision Therapeutics, Inc. | 6 | 43.0 |
| Accera, Inc. | 2 | 35.0 |
| Project Playlist, Inc. | 1 | 20.0 |
| IntelePeer, Inc. (FKA: VoEx, Inc.) | 4 | 18.0 |
| ImageShack Corporation | 1 | 15.0 |
| TD Security, Inc. (DBA: Trust Digital, LLC) | 6 | 14.5 |
| FlipSwap, Inc. | 2 | 14.0 |
| Evolution Robotics, Inc. | 4 | 13.88 |
| Digitalsmiths Corporation | 3 | 12.0 |
This is no gag. It's a serious offer. 
Top Private Capital Stories by Region
- Americas
- Europe
- Asia
Reuters Conferences
| Event | Date | Location |
|---|---|---|
| IFR's Mediterranean Covered Bonds | 27 Nov | Madrid |
| EVCJ's Venture Capital Fundraising Forum | 3 Dec | London |
| Buyouts Texas | 11-12 Dec | Dallas |
Private Capital News by Industry
Daiichi confident of Effient approval
NEW YORK (Reuters) - Daiichi-Sankyo's top U.S. executive expressed confidence that the blood clot preventer it is developing with Eli Lilly & Co will soon win U.S. approval, and said the sales force for the medicine was champing at the bit to get started. Full Article
